JULIA P. GREGORY - 06 May 2021 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
Director
Signature
/s/ Christine Ring, as Attorney-in-Fact for Julia P. Gregory
Issuer symbol
NRIX
Transactions as of
06 May 2021
Transactions value $
$0
Form type
4
Filing time
24 May 2021, 19:48:35 UTC
Previous filing
07 May 2021
Next filing
22 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRIX Director Stock Option (right to buy) Award $0 +17.5K $0.00 17.5K 06 May 2021 Common Stock 17.5K $27.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 6, 2022, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date.